The global market for robotic surgery systems is projected to reach $6.07 billion by 2024, yet just 2% of surgical procedures around the world are performed with a robot-assisted system today. Robotic surgery has been associated with many benefits, including lower health care costs, greater operating precision and flexibility, and quicker recovery times for patients. This presentation will look at current trends in the robotic surgery market, from the top companies innovating in this space, to the state-of-the-art technologies currently in development. Leveraging insights and analysis drawn from innovation intelligence, this presentation will dig into what’s contributing to the 2% adoption barrier and the hurdles that need to be overcome to drive widespread use of robotics in the health care industry.
Carl Rost, Solution Consultant, PatSnap
Host of Annual In-Person Emerging Medtech Summit
(recognized as the must-attend event by thought-leading strategics & VCs)
PatSnap is the leading innovation intelligence software solution, designed to help companies make better business decisions by providing world-class IP and R&D intelligence. With the application of AI and machine learning, PatSnap makes it possible to gain actionable intelligence from millions of global innovation data points such as patents, litigation, investment and company information. From ideation to commercialization, learn how connected innovation intelligence can help. Visit www.patsnap.com.
AEYE Health has developed a highly accurate system that can analyze fundus images, providing immediate diagnosis of all major and advanced retinal conditions.
KneeStim, is a light, form-fitting device that uses neuromuscular electrical stimulation (NMES) to stimulate quadriceps muscles in sync with regular activity, accelerating rehabilitation outside of the clinic by strengthening and training muscle with each step.
Co-founder & CEO
Genomic Expression (aka GEx)
Haermonics flush cleans the pericardial cavity after open-heart surgery to prevent complications.
A novel surface neurostimulation technology (called Neural Retinal Therapy™) to restore vision in those afflicted with Dry, Age-related Macular Degeneration (or Dry AMD).
President & CEO
President & Founder
LeukoLifeDx is a medical diagnostic company using gene expression profiling to guide the treatment of Advanced Heart Failure by providing quantitative patient survival outcome data.
Galit Zuckerman Stark
CEO, Founder & Board Member
Founder & CEO
Intra-operative monitor for real-time blood perfusion assessment which addresses a critical need in the peripheral vascular disease (PVD) market
Strata Medical Innovations
Inhaler/drug-delivery system for anxiety and pain
Synova Life Sciences
Focus groups have named our Kanega watch platform a wearable “OnStar for People” because we provide discreet support for falls, medication reminders, and a guard against wandering in a voice-first, classically-styled watch.
Jean Anne Booth
CEO & Co-founder
More companies coming soon!
Spotlight presenting companies get invaluable exposure to LSI's audience of medtech investors and strategics. If you are a medtech innovator seeking access to capital or strategic partners, fill out the application below to submit your company. If your application is approved we will be in touch with next steps.
Special Announcement: To support the medtech ecosystem during the coronavirus crisis, LSI is waiving (indefinitely) all fees for startups that pass this application process. This is our way of supporting the medtech industry during these difficult times.